Target intelligence / Profile preview

Importin-13 (IPO13)

Target
IPO13
Molecular classification
Nuclear transport receptor (Karyopherin superfamily), Transporter
01

Overview

Importin-13 (IPO13) is a unique member of the importin-β/Karyopherin superfamily that functions as a nuclear transport receptor, mediating both the import and export of a variety of cargo proteins across the nuclear envelope in a Ran-dependent (and sometimes Ran-independent) manner. IPO13 directs the nucleocytoplasmic trafficking of key regulatory proteins—including transcription factors like glucocorticoid receptor, SP1, KLF4, homeodomain proteins Pax6, ARX, UBC9, and others—integral to anti-inflammatory signaling, stress response, gene expression, and cell fate decisions. Unlike most importins, IPO13 is active even under cellular stress, controlling nuclear import (e.g., of nCLU, which promotes apoptosis) and regulating export (e.g., KU70, involved in DNA repair). IPO13 thereby influences the response to oxidative stress, cell cycle progression, and apoptosis, and its altered function or genetic mutations can contribute to developmental abnormalities and disease. Phosphorylation of IPO13 further modulates its subcellular localization and transport activity, with implications for distribution of transcription partners such as Pax6 in development[1][2][3][4][5].

Other names
Importin-13IPO13KIAA0724RANBP13Imp13Kap13RanBP13IMP13KAP13LGL2late gestation lung 2Karyopherin-13Ran-binding protein 13Ran binding protein 13
02

Mechanism of action

Not applicable/none known for drugs, but as a transporter, IPO13 mediates nuclear import of proteins such as UBC9, Pax6, Pax3, CRX, ARX, glucocorticoid receptor, and nuclear export of eIF1A, EIF4G2, HMG20A, KLF4, and SP1

03

Biological functions

Nucleocytoplasmic transport (bidirectional: import and export)Regulation of transcription factor localizationSignal transductionCellular stress responseCell fate decision (apoptosis vs. survival)Developmental processes (e.g., eye morphogenesis, testis, lung, and brain development)
04

Disease associations

Developmental disorders (e.g., microphthalmia, coloboma, cataract)Neurodevelopmental disease (e.g., Partington syndrome)Cellular stress responsesPotential role in cancer (through cell fate control/apoptosis)
05

Safety considerations

None highlighted for direct therapeutic targeting, but manipulating IPO13 may impact cell survival, apoptosis, and developmental pathways, potentially leading to unintended effects
06

Biomarkers

None formally identified as in clinical use.IPO13 expression/mutation status may have potential research value in ocular development and stress-related apoptosis

Beyond the preview

Go deeper on Importin-13 (IPO13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Importin-13 (IPO13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call